Mortality statistics in England and Wales: the SARS-CoV-2 paradox.


Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 1 7 2020
Statut: ppublish

Résumé

To analyse mortality statistics in the United Kingdom during the initial phases of the severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic and to understand the impact of the pandemic on national mortality. Retrospective review of weekly national mortality statistics in the United Kingdom over the past 5 years, including subgroup analysis of respiratory mortality rates. During the early phases of the SARS-CoV-2 pandemic in the first months of 2020, there were consistently fewer deaths per week compared with the preceding 5 years. This pattern was not observed at any other time within the past 5 years. We have termed this phenomenon the "SARS-CoV-2 paradox." We postulate potential explanations for this seeming paradox and explore the implications of these data. Paradoxically, but potentially importantly, lower rather than higher weekly mortality rates were observed during the early stages of the SARS-CoV-2 pandemic. This paradox may have implications for current and future healthcare utilisation. A rebound increase in non-SARS-CoV-2 mortality later this year might coincide with the peak of SARS-CoV-2 admissions and mortality.

Identifiants

pubmed: 32564639
doi: 10.1177/0300060520931298
pmc: PMC7307394
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300060520931298

Références

Lancet Respir Med. 2020 May;8(5):434-436
pubmed: 32203710
BMJ. 2020 Mar 17;368:m1089
pubmed: 32184205
Lancet Infect Dis. 2020 Jul;20(7):776-777
pubmed: 32224313
Lancet Infect Dis. 2020 Jul;20(7):773
pubmed: 32171390
CMAJ. 2003 Aug 19;169(4):277-8
pubmed: 12925409
Influenza Other Respir Viruses. 2020 Jul;14(4):472-473
pubmed: 32223072

Auteurs

Gabrielle Harrison (G)

Warwick Medical School, University of Warwick, Coventry, UK.
University Hospitals Coventry & Warwickshire, NHS Trust, Coventry, UK.

Daniel Newport (D)

Warwick Medical School, University of Warwick, Coventry, UK.
University Hospitals Coventry & Warwickshire, NHS Trust, Coventry, UK.

Tim Robbins (T)

University Hospitals Coventry & Warwickshire, NHS Trust, Coventry, UK.
Institute of Digital Healthcare, WMG, University of Warwick, Coventry, UK.

Theodoros N Arvanitis (TN)

Institute of Digital Healthcare, WMG, University of Warwick, Coventry, UK.

Andrew Stein (A)

University Hospitals Coventry & Warwickshire, NHS Trust, Coventry, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH